| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Osteocytes | 30 | 2023 | 33 | 9.040 |
Why?
|
| Bone and Bones | 25 | 2022 | 115 | 4.630 |
Why?
|
| Stress, Mechanical | 18 | 2023 | 162 | 1.960 |
Why?
|
| Bone Resorption | 12 | 2020 | 22 | 1.840 |
Why?
|
| Mechanotransduction, Cellular | 8 | 2023 | 59 | 1.810 |
Why?
|
| Bone Density | 15 | 2022 | 102 | 1.720 |
Why?
|
| Apoptosis | 10 | 2020 | 1541 | 1.700 |
Why?
|
| Bone Remodeling | 11 | 2020 | 23 | 1.530 |
Why?
|
| Connexins | 6 | 2021 | 28 | 1.510 |
Why?
|
| Osteoclasts | 10 | 2020 | 28 | 1.350 |
Why?
|
| Nerve Tissue Proteins | 6 | 2021 | 382 | 1.270 |
Why?
|
| RANK Ligand | 5 | 2020 | 19 | 1.260 |
Why?
|
| Osteogenesis | 7 | 2014 | 57 | 1.190 |
Why?
|
| Insulin-Like Growth Factor I | 11 | 2024 | 81 | 1.170 |
Why?
|
| Animals | 77 | 2024 | 16695 | 1.160 |
Why?
|
| Femur | 9 | 2016 | 46 | 1.160 |
Why?
|
| Osteoporosis | 7 | 2015 | 48 | 1.090 |
Why?
|
| Cell Communication | 4 | 2017 | 110 | 1.020 |
Why?
|
| Mice | 42 | 2024 | 6490 | 0.930 |
Why?
|
| Signal Transduction | 7 | 2020 | 2111 | 0.920 |
Why?
|
| Tibia | 8 | 2016 | 26 | 0.910 |
Why?
|
| Calcium Signaling | 2 | 2023 | 108 | 0.850 |
Why?
|
| Ulna | 2 | 2014 | 3 | 0.830 |
Why?
|
| Mice, Inbred C57BL | 24 | 2024 | 1804 | 0.820 |
Why?
|
| Aging | 8 | 2024 | 764 | 0.700 |
Why?
|
| Weight-Bearing | 10 | 2016 | 31 | 0.650 |
Why?
|
| Calcium | 3 | 2023 | 487 | 0.630 |
Why?
|
| Bone Development | 9 | 2018 | 28 | 0.630 |
Why?
|
| Growth Hormone | 4 | 2024 | 35 | 0.630 |
Why?
|
| Calcium Channels, T-Type | 1 | 2017 | 4 | 0.560 |
Why?
|
| Integrin beta3 | 1 | 2017 | 7 | 0.560 |
Why?
|
| Cathepsins | 2 | 2009 | 10 | 0.560 |
Why?
|
| Osteolysis | 1 | 2016 | 3 | 0.530 |
Why?
|
| Rats | 21 | 2016 | 3701 | 0.520 |
Why?
|
| Elastic Modulus | 1 | 2016 | 20 | 0.520 |
Why?
|
| Humerus | 2 | 2015 | 4 | 0.510 |
Why?
|
| Lactation | 1 | 2016 | 44 | 0.510 |
Why?
|
| Female | 42 | 2024 | 24018 | 0.510 |
Why?
|
| Hindlimb Suspension | 1 | 2016 | 16 | 0.500 |
Why?
|
| Bystander Effect | 1 | 2016 | 15 | 0.490 |
Why?
|
| Mitochondria | 2 | 2018 | 516 | 0.490 |
Why?
|
| Elasticity | 3 | 2015 | 50 | 0.480 |
Why?
|
| Rats, Sprague-Dawley | 19 | 2016 | 1737 | 0.480 |
Why?
|
| Mice, Knockout | 15 | 2024 | 1010 | 0.470 |
Why?
|
| Etidronic Acid | 2 | 2005 | 4 | 0.470 |
Why?
|
| Ulna Fractures | 1 | 2014 | 1 | 0.460 |
Why?
|
| Bone Regeneration | 1 | 2014 | 10 | 0.450 |
Why?
|
| Bone Matrix | 3 | 2016 | 8 | 0.430 |
Why?
|
| Cartilage, Articular | 5 | 2019 | 12 | 0.430 |
Why?
|
| Bone Diseases, Metabolic | 4 | 2021 | 14 | 0.430 |
Why?
|
| Tendons | 5 | 2011 | 9 | 0.400 |
Why?
|
| X-Ray Microtomography | 7 | 2017 | 22 | 0.360 |
Why?
|
| Fractures, Bone | 4 | 2006 | 61 | 0.360 |
Why?
|
| Diphosphonates | 2 | 2015 | 18 | 0.340 |
Why?
|
| Ovariectomy | 4 | 2021 | 128 | 0.330 |
Why?
|
| Extracellular Matrix | 3 | 2013 | 129 | 0.310 |
Why?
|
| Joints | 4 | 2010 | 13 | 0.310 |
Why?
|
| Cell Differentiation | 6 | 2015 | 633 | 0.310 |
Why?
|
| Growth Plate | 1 | 2009 | 2 | 0.300 |
Why?
|
| Patellar Ligament | 4 | 2014 | 5 | 0.290 |
Why?
|
| Calcinosis | 1 | 2009 | 61 | 0.290 |
Why?
|
| Time Factors | 7 | 2016 | 1848 | 0.290 |
Why?
|
| Gene Expression Regulation | 7 | 2017 | 1066 | 0.280 |
Why?
|
| Male | 27 | 2024 | 22779 | 0.270 |
Why?
|
| Disease Models, Animal | 8 | 2014 | 1554 | 0.260 |
Why?
|
| Osteopetrosis | 1 | 2006 | 3 | 0.250 |
Why?
|
| Laron Syndrome | 2 | 2018 | 3 | 0.250 |
Why?
|
| Calcification, Physiologic | 3 | 2012 | 18 | 0.230 |
Why?
|
| Dogs | 4 | 2015 | 201 | 0.230 |
Why?
|
| Actins | 3 | 2007 | 162 | 0.230 |
Why?
|
| Bone Marrow | 2 | 2015 | 35 | 0.230 |
Why?
|
| Carrier Proteins | 3 | 2017 | 318 | 0.220 |
Why?
|
| Spectrum Analysis, Raman | 2 | 2021 | 94 | 0.220 |
Why?
|
| Cell Line | 6 | 2020 | 1416 | 0.220 |
Why?
|
| Liver | 2 | 2017 | 503 | 0.220 |
Why?
|
| Fluorescent Dyes | 1 | 2005 | 182 | 0.220 |
Why?
|
| Mitochondrial Diseases | 1 | 2024 | 19 | 0.210 |
Why?
|
| Ubiquinone | 1 | 2024 | 22 | 0.210 |
Why?
|
| Organophosphorus Compounds | 1 | 2024 | 37 | 0.210 |
Why?
|
| Microfilament Proteins | 2 | 2015 | 72 | 0.200 |
Why?
|
| Fatigue | 3 | 2014 | 97 | 0.200 |
Why?
|
| Coloring Agents | 1 | 2023 | 56 | 0.200 |
Why?
|
| Mesenchymal Stem Cells | 2 | 2015 | 72 | 0.200 |
Why?
|
| Acromegaly | 1 | 2022 | 3 | 0.200 |
Why?
|
| Receptors, Somatotropin | 3 | 2024 | 18 | 0.190 |
Why?
|
| Longevity | 1 | 2024 | 171 | 0.190 |
Why?
|
| Body Composition | 2 | 2021 | 160 | 0.190 |
Why?
|
| Immunohistochemistry | 6 | 2013 | 928 | 0.190 |
Why?
|
| Tendinopathy | 2 | 2014 | 4 | 0.180 |
Why?
|
| Models, Biological | 6 | 2009 | 711 | 0.180 |
Why?
|
| Models, Animal | 5 | 2014 | 149 | 0.180 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2002 | 152 | 0.180 |
Why?
|
| Anisotropy | 5 | 2015 | 33 | 0.180 |
Why?
|
| Estrogens | 2 | 2021 | 202 | 0.170 |
Why?
|
| Antioxidants | 1 | 2024 | 439 | 0.160 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2002 | 255 | 0.160 |
Why?
|
| Osteoprotegerin | 3 | 2017 | 17 | 0.160 |
Why?
|
| Trans-Activators | 2 | 2019 | 190 | 0.160 |
Why?
|
| Interleukin-4 | 1 | 2019 | 75 | 0.150 |
Why?
|
| Periosteum | 2 | 2016 | 3 | 0.150 |
Why?
|
| Enzyme Inhibitors | 3 | 2010 | 457 | 0.150 |
Why?
|
| Repressor Proteins | 2 | 2019 | 267 | 0.140 |
Why?
|
| Caspase 3 | 3 | 2016 | 226 | 0.140 |
Why?
|
| Receptors, Purinergic | 1 | 2017 | 6 | 0.140 |
Why?
|
| Cathepsin K | 2 | 2009 | 2 | 0.140 |
Why?
|
| Receptors, Purinergic P2 | 2 | 2017 | 15 | 0.140 |
Why?
|
| Chondrocytes | 2 | 2014 | 15 | 0.140 |
Why?
|
| Lab-On-A-Chip Devices | 1 | 2017 | 37 | 0.130 |
Why?
|
| Glycoproteins | 2 | 2017 | 127 | 0.130 |
Why?
|
| Cell Size | 1 | 2016 | 46 | 0.130 |
Why?
|
| Dendritic Cells | 1 | 2017 | 130 | 0.130 |
Why?
|
| Humans | 16 | 2019 | 42163 | 0.130 |
Why?
|
| Rhodamines | 1 | 2016 | 23 | 0.130 |
Why?
|
| Microscopy, Fluorescence, Multiphoton | 1 | 2016 | 16 | 0.130 |
Why?
|
| Cell Hypoxia | 1 | 2016 | 57 | 0.120 |
Why?
|
| NAD | 1 | 2016 | 45 | 0.120 |
Why?
|
| Adenosine Triphosphatases | 1 | 2016 | 83 | 0.120 |
Why?
|
| Parathyroid Hormone | 1 | 2015 | 40 | 0.120 |
Why?
|
| Hindlimb | 3 | 2010 | 32 | 0.120 |
Why?
|
| Microscopy, Fluorescence | 2 | 2017 | 254 | 0.120 |
Why?
|
| Stem Cell Niche | 1 | 2015 | 11 | 0.120 |
Why?
|
| Reactive Oxygen Species | 1 | 2018 | 518 | 0.120 |
Why?
|
| Hot Temperature | 1 | 2016 | 141 | 0.120 |
Why?
|
| Osteoblasts | 3 | 2017 | 44 | 0.120 |
Why?
|
| Immobilization | 2 | 2005 | 11 | 0.120 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2015 | 78 | 0.110 |
Why?
|
| Cells, Cultured | 5 | 2012 | 1617 | 0.110 |
Why?
|
| Mice, Transgenic | 4 | 2022 | 658 | 0.110 |
Why?
|
| Porosity | 1 | 2015 | 42 | 0.110 |
Why?
|
| Cervical Vertebrae | 1 | 2014 | 18 | 0.110 |
Why?
|
| Diabetes Mellitus, Type 2 | 2 | 2016 | 744 | 0.110 |
Why?
|
| Osteoarthritis | 1 | 2014 | 25 | 0.110 |
Why?
|
| Oxidation-Reduction | 1 | 2016 | 448 | 0.110 |
Why?
|
| Matrix Metalloproteinase 13 | 2 | 2019 | 5 | 0.110 |
Why?
|
| Tea | 1 | 2014 | 46 | 0.110 |
Why?
|
| Catechin | 1 | 2014 | 38 | 0.110 |
Why?
|
| Ultrasonography | 1 | 2015 | 132 | 0.110 |
Why?
|
| Cell Surface Extensions | 1 | 2013 | 9 | 0.110 |
Why?
|
| Transforming Growth Factor beta | 1 | 2015 | 214 | 0.110 |
Why?
|
| Blood Glucose | 1 | 2016 | 386 | 0.110 |
Why?
|
| Anabolic Agents | 1 | 2014 | 19 | 0.100 |
Why?
|
| Integrin alphaVbeta3 | 1 | 2013 | 17 | 0.100 |
Why?
|
| Hormones | 1 | 2014 | 56 | 0.100 |
Why?
|
| Restraint, Physical | 2 | 2010 | 22 | 0.100 |
Why?
|
| Matrix Metalloproteinase 1 | 2 | 2010 | 26 | 0.100 |
Why?
|
| Cell Lineage | 2 | 2011 | 104 | 0.100 |
Why?
|
| Wound Healing | 2 | 2011 | 82 | 0.100 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2014 | 184 | 0.100 |
Why?
|
| Stem Cells | 2 | 2010 | 151 | 0.090 |
Why?
|
| Cell Adhesion | 1 | 2013 | 237 | 0.090 |
Why?
|
| Metabolism | 1 | 2011 | 9 | 0.090 |
Why?
|
| Microfibrils | 1 | 2011 | 1 | 0.090 |
Why?
|
| Torsion, Mechanical | 1 | 2011 | 4 | 0.090 |
Why?
|
| Adult Stem Cells | 1 | 2011 | 12 | 0.090 |
Why?
|
| Bone Morphogenetic Proteins | 1 | 2011 | 27 | 0.090 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 5 | 2010 | 649 | 0.090 |
Why?
|
| Cattle | 3 | 2022 | 505 | 0.080 |
Why?
|
| Regeneration | 1 | 2010 | 29 | 0.080 |
Why?
|
| Tissue Engineering | 1 | 2011 | 72 | 0.080 |
Why?
|
| Fourier Analysis | 1 | 2010 | 45 | 0.080 |
Why?
|
| Arthrometry, Articular | 1 | 2009 | 1 | 0.080 |
Why?
|
| Matrix Metalloproteinase 3 | 1 | 2010 | 16 | 0.080 |
Why?
|
| Physical Stimulation | 1 | 2009 | 27 | 0.080 |
Why?
|
| Microscopy | 1 | 2010 | 33 | 0.080 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 3 | 3 | 2017 | 27 | 0.080 |
Why?
|
| Fluorescence Recovery After Photobleaching | 2 | 2009 | 9 | 0.080 |
Why?
|
| Microscopy, Electron | 1 | 2010 | 209 | 0.080 |
Why?
|
| Diffusion | 2 | 2009 | 63 | 0.080 |
Why?
|
| Angiogenesis Inhibitors | 1 | 2009 | 62 | 0.080 |
Why?
|
| Amino Acid Chloromethyl Ketones | 1 | 2009 | 8 | 0.080 |
Why?
|
| Tendon Injuries | 1 | 2009 | 3 | 0.080 |
Why?
|
| Neovascularization, Physiologic | 1 | 2009 | 80 | 0.080 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2010 | 167 | 0.080 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2009 | 100 | 0.070 |
Why?
|
| Mesoderm | 1 | 2009 | 73 | 0.070 |
Why?
|
| Transcription Factors | 2 | 2010 | 722 | 0.070 |
Why?
|
| Carbohydrate Metabolism | 1 | 2008 | 26 | 0.070 |
Why?
|
| Organ Size | 3 | 2017 | 167 | 0.070 |
Why?
|
| Quinolines | 1 | 2009 | 76 | 0.070 |
Why?
|
| Polymers | 1 | 2009 | 151 | 0.070 |
Why?
|
| Forelimb | 2 | 2006 | 23 | 0.070 |
Why?
|
| Drug Carriers | 1 | 2009 | 169 | 0.070 |
Why?
|
| Selective Estrogen Receptor Modulators | 1 | 2008 | 31 | 0.070 |
Why?
|
| Interleukin-1beta | 1 | 2008 | 74 | 0.070 |
Why?
|
| Research Design | 1 | 2010 | 370 | 0.070 |
Why?
|
| Menopause | 1 | 2008 | 63 | 0.070 |
Why?
|
| Cell Line, Transformed | 2 | 2019 | 96 | 0.070 |
Why?
|
| Collagen Type I | 2 | 2022 | 35 | 0.070 |
Why?
|
| Random Allocation | 3 | 2017 | 145 | 0.070 |
Why?
|
| Androgens | 1 | 2008 | 107 | 0.070 |
Why?
|
| Integrins | 1 | 2007 | 54 | 0.070 |
Why?
|
| Plastic Embedding | 1 | 2007 | 3 | 0.070 |
Why?
|
| Drug Delivery Systems | 1 | 2009 | 273 | 0.070 |
Why?
|
| Receptors, Androgen | 1 | 2008 | 144 | 0.070 |
Why?
|
| Matrix Metalloproteinase 2 | 1 | 2007 | 51 | 0.070 |
Why?
|
| Metacarpal Bones | 1 | 2006 | 1 | 0.070 |
Why?
|
| Sexual Maturation | 1 | 2006 | 24 | 0.060 |
Why?
|
| Mice, Mutant Strains | 2 | 2018 | 85 | 0.060 |
Why?
|
| Follicle Stimulating Hormone | 1 | 2006 | 44 | 0.060 |
Why?
|
| Atherosclerosis | 1 | 2008 | 164 | 0.060 |
Why?
|
| Transgenes | 2 | 2017 | 65 | 0.060 |
Why?
|
| Solutions | 1 | 2005 | 65 | 0.060 |
Why?
|
| Fractures, Stress | 1 | 2005 | 2 | 0.060 |
Why?
|
| Tibial Fractures | 1 | 2005 | 2 | 0.060 |
Why?
|
| Solubility | 1 | 2005 | 134 | 0.060 |
Why?
|
| Biological Transport | 1 | 2005 | 201 | 0.060 |
Why?
|
| Collagen | 3 | 2011 | 178 | 0.060 |
Why?
|
| Calcium Channel Blockers | 1 | 2004 | 57 | 0.060 |
Why?
|
| Methylene Blue | 1 | 2024 | 7 | 0.050 |
Why?
|
| Rheology | 1 | 2004 | 51 | 0.050 |
Why?
|
| Drug Resistance | 1 | 2004 | 97 | 0.050 |
Why?
|
| Chemistry, Physical | 1 | 2004 | 50 | 0.050 |
Why?
|
| Chemical Phenomena | 1 | 2004 | 56 | 0.050 |
Why?
|
| Oxidative Stress | 2 | 2024 | 990 | 0.050 |
Why?
|
| Protein Subunits | 2 | 2017 | 93 | 0.050 |
Why?
|
| Mice, Inbred BALB C | 1 | 2004 | 686 | 0.050 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2006 | 727 | 0.050 |
Why?
|
| Bone Demineralization Technique | 1 | 2002 | 2 | 0.050 |
Why?
|
| Cyclooxygenase 2 | 2 | 2016 | 106 | 0.050 |
Why?
|
| bcl-2-Associated X Protein | 1 | 2002 | 76 | 0.050 |
Why?
|
| RNA, Small Interfering | 2 | 2017 | 436 | 0.040 |
Why?
|
| Bone Marrow Cells | 2 | 2011 | 79 | 0.040 |
Why?
|
| Adaptation, Physiological | 2 | 2011 | 135 | 0.040 |
Why?
|
| Image Processing, Computer-Assisted | 2 | 2013 | 170 | 0.040 |
Why?
|
| Rupture | 2 | 2009 | 5 | 0.040 |
Why?
|
| Protein Binding | 2 | 2014 | 1076 | 0.040 |
Why?
|
| Body Weight | 2 | 2014 | 428 | 0.040 |
Why?
|
| beta Catenin | 1 | 2018 | 75 | 0.030 |
Why?
|
| Paracrine Communication | 1 | 2017 | 18 | 0.030 |
Why?
|
| Osteopontin | 1 | 2017 | 45 | 0.030 |
Why?
|
| Organ Specificity | 1 | 2017 | 141 | 0.030 |
Why?
|
| Fatty Liver | 1 | 2017 | 71 | 0.030 |
Why?
|
| Gene Expression | 2 | 2010 | 692 | 0.030 |
Why?
|
| Macrophage Colony-Stimulating Factor | 1 | 2016 | 10 | 0.030 |
Why?
|
| Interleukin-1alpha | 1 | 2016 | 18 | 0.030 |
Why?
|
| Inflammation Mediators | 1 | 2017 | 138 | 0.030 |
Why?
|
| Fibroblast Growth Factors | 1 | 2015 | 36 | 0.030 |
Why?
|
| Adolescent | 2 | 2005 | 5950 | 0.030 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2016 | 180 | 0.030 |
Why?
|
| RNA, Messenger | 2 | 2010 | 1265 | 0.030 |
Why?
|
| Phosphorus | 1 | 2015 | 65 | 0.030 |
Why?
|
| Cilia | 1 | 2014 | 29 | 0.030 |
Why?
|
| Sheep | 1 | 2014 | 77 | 0.030 |
Why?
|
| Sensitivity and Specificity | 2 | 2009 | 602 | 0.030 |
Why?
|
| Mutation | 2 | 2010 | 1169 | 0.030 |
Why?
|
| Palliative Care | 1 | 2014 | 61 | 0.030 |
Why?
|
| Chronic Disease | 1 | 2017 | 541 | 0.030 |
Why?
|
| Crosses, Genetic | 1 | 2014 | 48 | 0.030 |
Why?
|
| Aged | 2 | 2004 | 7982 | 0.030 |
Why?
|
| Glucose Tolerance Test | 1 | 2014 | 76 | 0.030 |
Why?
|
| Cytokines | 1 | 2017 | 661 | 0.030 |
Why?
|
| Apyrase | 1 | 2013 | 3 | 0.030 |
Why?
|
| Fluorescence | 1 | 2013 | 113 | 0.030 |
Why?
|
| Hormone Replacement Therapy | 1 | 2013 | 49 | 0.030 |
Why?
|
| Patch-Clamp Techniques | 1 | 2013 | 228 | 0.020 |
Why?
|
| Reproducibility of Results | 2 | 2009 | 1058 | 0.020 |
Why?
|
| Cell Proliferation | 2 | 2010 | 1420 | 0.020 |
Why?
|
| Inflammation | 1 | 2017 | 729 | 0.020 |
Why?
|
| Insulin | 1 | 2014 | 255 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2013 | 574 | 0.020 |
Why?
|
| Middle Aged | 2 | 2005 | 11819 | 0.020 |
Why?
|
| Diaphyses | 1 | 2011 | 1 | 0.020 |
Why?
|
| Compressive Strength | 1 | 2011 | 18 | 0.020 |
Why?
|
| Carbonates | 1 | 2011 | 4 | 0.020 |
Why?
|
| Calcaneus | 1 | 2011 | 4 | 0.020 |
Why?
|
| Implants, Experimental | 1 | 2011 | 6 | 0.020 |
Why?
|
| Phosphates | 1 | 2011 | 54 | 0.020 |
Why?
|
| Phenotype | 1 | 2014 | 774 | 0.020 |
Why?
|
| Tissue Inhibitor of Metalloproteinases | 1 | 2010 | 5 | 0.020 |
Why?
|
| Tissue Scaffolds | 1 | 2011 | 31 | 0.020 |
Why?
|
| Hydrostatic Pressure | 1 | 2010 | 9 | 0.020 |
Why?
|
| Proto-Oncogene Protein c-ets-1 | 1 | 2010 | 9 | 0.020 |
Why?
|
| p300-CBP Transcription Factors | 1 | 2010 | 14 | 0.020 |
Why?
|
| Tissue Culture Techniques | 1 | 2010 | 36 | 0.020 |
Why?
|
| Postmenopause | 1 | 2011 | 139 | 0.020 |
Why?
|
| Finite Element Analysis | 1 | 2010 | 16 | 0.020 |
Why?
|
| Matrix Metalloproteinases | 1 | 2010 | 49 | 0.020 |
Why?
|
| Adult | 2 | 2005 | 13458 | 0.020 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2011 | 88 | 0.020 |
Why?
|
| Phenazines | 1 | 2010 | 6 | 0.020 |
Why?
|
| ADAM Proteins | 1 | 2010 | 20 | 0.020 |
Why?
|
| Collagen Type V | 1 | 2009 | 2 | 0.020 |
Why?
|
| Hexuronic Acids | 1 | 2009 | 8 | 0.020 |
Why?
|
| Glucuronic Acid | 1 | 2009 | 8 | 0.020 |
Why?
|
| Collagen Type III | 1 | 2009 | 9 | 0.020 |
Why?
|
| Equipment Failure Analysis | 1 | 2009 | 45 | 0.020 |
Why?
|
| Polyesters | 1 | 2009 | 26 | 0.020 |
Why?
|
| Alginates | 1 | 2009 | 19 | 0.020 |
Why?
|
| Ischemia | 1 | 2009 | 45 | 0.020 |
Why?
|
| Equipment Design | 1 | 2009 | 143 | 0.020 |
Why?
|
| RNA Interference | 1 | 2010 | 246 | 0.020 |
Why?
|
| Delayed-Action Preparations | 1 | 2009 | 72 | 0.020 |
Why?
|
| Molecular Weight | 1 | 2009 | 168 | 0.020 |
Why?
|
| DNA Primers | 1 | 2009 | 295 | 0.020 |
Why?
|
| Acid Phosphatase | 1 | 2008 | 23 | 0.020 |
Why?
|
| Insulin-Like Growth Factor Binding Proteins | 1 | 2008 | 5 | 0.020 |
Why?
|
| Cell Cycle | 1 | 2010 | 348 | 0.020 |
Why?
|
| Flow Cytometry | 1 | 2010 | 411 | 0.020 |
Why?
|
| Adiposity | 1 | 2010 | 155 | 0.020 |
Why?
|
| Cumulative Trauma Disorders | 1 | 2008 | 5 | 0.020 |
Why?
|
| Isoenzymes | 1 | 2008 | 169 | 0.020 |
Why?
|
| Blotting, Western | 1 | 2010 | 884 | 0.020 |
Why?
|
| Base Sequence | 1 | 2009 | 997 | 0.020 |
Why?
|
| Weight Gain | 1 | 2008 | 138 | 0.020 |
Why?
|
| Cloning, Molecular | 1 | 2008 | 318 | 0.020 |
Why?
|
| Rabbits | 1 | 2008 | 292 | 0.020 |
Why?
|
| Membrane Proteins | 1 | 2011 | 548 | 0.020 |
Why?
|
| Acrylic Resins | 1 | 2007 | 12 | 0.020 |
Why?
|
| Plasmids | 1 | 2008 | 247 | 0.020 |
Why?
|
| Arthritis | 1 | 2007 | 18 | 0.020 |
Why?
|
| Craniofacial Abnormalities | 1 | 2007 | 24 | 0.020 |
Why?
|
| Receptors, LHRH | 1 | 2006 | 3 | 0.020 |
Why?
|
| Chemokine CCL2 | 1 | 2008 | 95 | 0.020 |
Why?
|
| Gonadotropin-Releasing Hormone | 1 | 2006 | 39 | 0.020 |
Why?
|
| Pattern Recognition, Automated | 1 | 2006 | 32 | 0.020 |
Why?
|
| Gene Deletion | 1 | 2007 | 168 | 0.020 |
Why?
|
| Receptors, FSH | 1 | 2006 | 8 | 0.020 |
Why?
|
| GTP-Binding Protein alpha Subunit, Gi2 | 1 | 2006 | 4 | 0.020 |
Why?
|
| Hypogonadism | 1 | 2006 | 23 | 0.020 |
Why?
|
| Ovary | 1 | 2006 | 112 | 0.020 |
Why?
|
| Haversian System | 1 | 2005 | 3 | 0.020 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2006 | 98 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2007 | 246 | 0.010 |
Why?
|
| Mice, Inbred C3H | 1 | 2005 | 80 | 0.010 |
Why?
|
| Mice, Inbred Strains | 1 | 2005 | 116 | 0.010 |
Why?
|
| Uterus | 1 | 2005 | 57 | 0.010 |
Why?
|
| Enzyme Activation | 1 | 2006 | 462 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2008 | 577 | 0.010 |
Why?
|
| Cytoskeleton | 1 | 2004 | 111 | 0.010 |
Why?
|
| Computer Simulation | 1 | 2006 | 404 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2006 | 297 | 0.010 |
Why?
|
| Microscopy, Confocal | 1 | 2004 | 223 | 0.010 |
Why?
|
| NF-kappa B | 1 | 2006 | 355 | 0.010 |
Why?
|
| Formates | 1 | 2002 | 6 | 0.010 |
Why?
|
| Citrates | 1 | 2002 | 20 | 0.010 |
Why?
|
| Edetic Acid | 1 | 2002 | 23 | 0.010 |
Why?
|
| Age Factors | 1 | 2005 | 1139 | 0.010 |
Why?
|
| Reference Values | 1 | 2002 | 207 | 0.010 |
Why?
|
| Glucose | 1 | 2002 | 242 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2004 | 2803 | 0.010 |
Why?
|
| Risk Factors | 1 | 2005 | 3942 | 0.010 |
Why?
|